Oral delivery of chitosan-bilirubin nanoparticles alleviates hepatic inflammation and fibrosis in metabolic dysfunction-associated steatohepatitis
- Biomaterials, Jul 25 2025, 325 S0142-9612(25)00495-8 | https://doi.org/10.1016/j.biomaterials.2025.123576